Graft failure after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Graft failure after allogeneic hematopoietic stem cell transplantation

Published:2018-04 Issue:2 Volume:57 Page:163-167
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Ozdemir Zehra Narli,Civriz Bozdağ Sinem

Publisher

Elsevier BV

Subject

Hematology

Reference51 articles.

1. Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients;Ferra;Leuk Lymph,2015

2. T cell-depleted related HLA-mismatched peripheral blood stem cell transplantation as salvage therapy for graft failure after single unit unrelated donor umbilical cord blood transplantation;Moscardo;Biol Blood Marrow Transpl,2014

3. Immunological basis of bone marrow failure after allogeneic hematopoietic stem cell transplantation;Masouridi-Levrat;Front Immunol,2016

4. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation;Larocca;Haematologica,2006

5. Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis;Rondon;Biol Blood Marrow Transpl,2008

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian tissue cryopreservation after graft failure of allogeneic hematopoietic stem cell transplantation: first report and literature review;Frontiers in Endocrinology;2024-08-26

2. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know;Oncology and Therapy;2024-06-15

3. Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia;Transplant Immunology;2024-06

4. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-06

5. Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide;Transplantation and Cellular Therapy;2024-05